HIV and Women: What CDC Is Doing

CDC is pursuing a high-impact HIV prevention approach to maximize the effectiveness of HIV prevention interventions and strategies. Funding state, territorial, and local health departments and community-based organizations (CBOs) to develop and implement tailored programs is CDC’s largest investment in HIV prevention. This includes longstanding successful programs and new efforts funded through the Ending the HIV Epidemic in the U.S. initiative. In addition to funding health departments and CBOs, CDC is also strengthening the HIV prevention workforce and developing HIV communication resources for consumers and health care providers.

  • Under the integrated HIV surveillance and prevention cooperative agreement, CDC awards around $400 million per year to health departments for HIV data collection and prevention efforts. This award directs resources to the populations and geographic areas of greatest need, while supporting core HIV surveillance and prevention efforts across the US.
  • In 2019, CDC awarded $12 million to support the development of state and local Ending the HIV Epidemic in the U.S. plans in the nation’s 57 priority areas. To further enhance capacity building efforts, CDC uses HIV prevention resources to fund the National Alliance of State and Territorial AIDS Directors (NASTAD) with $1.5 million per year to support strategic partnerships, community engagement, peer-to-peer technical assistance, and planning efforts.
  • In 2020, CDC awarded $109 million to 32 state and local health departments that represent the 57 jurisdictions across the United States prioritized in the Ending the HIV Epidemic in the U.S. This award supports the implementation of state and local Ending the HIV Epidemic in the U.S. plans.
  • Under the flagship community-based organization cooperative agreement, CDC awards about $42 million per year to community-based organizations. This award directs resources to support the delivery of effective HIV prevention strategies to key populations.
  • In 2019, CDC awarded a cooperative agreement to strengthen the capacity and improve the performance of the nation’s HIV prevention workforce. New elements include dedicated providers for web-based and classroom-based national training, and technical assistance tailored within four geographic regions.
  • CDC’s Prevention Research Synthesis (PRS) Project identifies evidence-based interventions and best practices through ongoing systematic reviews. The PRS Project has identified several interventions for women in its Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention:
    • The CHAT Interventionpdf icon encourages women to discuss HIV and STD prevention with their family, friends, and sex partners.
    • AMIGASpdf icon emphasizes the importance of healthy relationships, raises awareness about HIV prevention strategies, and explores how cultural experiences can affect HIV risk.
    • Healthy Lovepdf icon empowers women to choose safer sex options by improving their knowledge about HIV testing, transmission, and prevention.
  • Through its Let’s Stop HIV Together campaign, CDC offers resources about HIV stigma, testing, prevention, and treatment and care. This campaign is part of the Ending the HIV Epidemic in the U.S. initiative.
  1. CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States, 2018 cycle (June 2018–May 2019) pdf icon[PDF – 905 KB]HIV Surveillance Special Report 2020;25.
  2. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018 pdf icon[PDF – 7 MB]HIV Surveillance Report 2020;31.
  3. CDC. Estimated HIV incidence and prevalence in the United States, 2014-2018 pdf icon[PDF – 3 MB]HIV Surveillance Supplemental Report 2020;25(1).
  4. CDC. HIV infection risk, prevention, and testing behaviors among heterosexually active adults at increased risk for HIV infection–National HIV Behavioral Surveillance – 23 U.S. Cities, 2019 pdf icon[PDF – 3 MB]. HIV Surveillance Special Report 2021; 26.
  5. CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs–National HIV Behavioral Surveillance: injection drug use – 23 U.S. Cities, 2018 pdf icon[PDF – 2 MB]. HIV Surveillance Special Report 2020; 24.
  6. CDC. HIV risk behaviors. Accessed January 28, 2020.
  7. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018 pdf icon[PDF – 4 MB]HIV Surveillance Supplemental Report 2020;25(2).
  8. CDC. Selected national HIV prevention and care outcomes pdf icon[PDF – 2 MB] [slides].
  9. CDC. Social determinants of health among adults with diagnosed HIV infection, 2018 pdf icon[PDF – 10 MB]. HIV Surveillance Supplemental Report 2020;25(3).
  10. CDC. Sexually transmitted disease surveillance, 2018. Accessed January 28, 2020.
  11. Bradley E, Forsberg K, Betts JE, et al. Factors affecting pre-exposure prophylaxis implementation for women in the United States: A systematic review. J Womens Health 2019;28(9):1272-85. PubMed abstractexternal icon.
  12. Evans ME, Tao G, Porter SE, Gray SC, Huang YA, Hoover KW. Low HIV testing rates among US women who report anal sex and other HIV sexual risk behaviors, 2011-2015. Am J Obstet Gynecol 2018;219(4):1-7. PubMed abstractexternal icon.
  13. McCree DH, Koenig LJ, Basile K, Fowler D, Green Y. Addressing the intersection of HIV and intimate partner violence among women with or at risk for HIV in the United States. J Womens Health 2015; 24(5):331-335. PubMed abstractexternal icon.
  14. Waldron M, Burnett-Zeigler I, Wee V, et al. Mental health in women living with HIV: The unique and unmet needs. J Int Assoc Provid AIDS Care 2021;20:1-18. PubMed abstractexternal icon.